LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
TRVICIK 0001563880

Trevi Therapeutics, Inc.

19 transactions by 11 insiders, from January 8, 2026 to September 15, 2026.

Transactions
1911 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
$596Kopen market
Net
−$596Knet selling

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Michael Thomas HeffernanDir9——$596K
Jennifer L. GoodCEO1———
Thomas SciasciaChief1———
David C. HastingsCFO1———
Dominick ColangeloDir1———
Edward T. MathersDir1———
James Cassella VChief1———
David P. MeekerDir1———
Christopher GallettaOfficer1———
Anne VanlentDir1———
Farrell SimonChief1———

All transactions

19 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Michael Thomas HeffernanDERIVSep 15M21,052$0.00—?
Michael Thomas HeffernanDERIVSep 15M18,421$0.00—?
Michael Thomas HeffernanSep 15S100$15.88$2K
Michael Thomas HeffernanSep 15S20,952$15.09$316K
Michael Thomas HeffernanSep 15M21,052$3.33$70K
Michael Thomas HeffernanSep 15S100$15.88$2K
Michael Thomas HeffernanSep 15S18,321$15.09$276K
Michael Thomas HeffernanSep 15M18,421$3.04$56K
Anne VanlentDirDERIVJun 3A35,000$0.00—?
David P. MeekerDirDERIVJun 3A35,000$0.00—?
Edward T. MathersDirDERIVJun 3A35,000$0.00—?
Michael Thomas HeffernanDirDERIVJun 3A35,000$0.00—?
Dominick ColangeloDirDERIVJun 3A35,000$0.00—?
Farrell SimonChiefDERIVFeb 19A160,000$0.00—?
Thomas SciasciaChiefDERIVFeb 19A85,000$0.00—?
Christopher GallettaOfficerDERIVFeb 19A35,000$0.00—?
Jennifer L. GoodCEODERIVFeb 19A675,000$0.00—?
James Cassella VChiefDERIVFeb 19A215,000$0.00—?
David C. HastingsCFODERIVJan 8A375,000$0.00—?